Micro-Leads Receives FDA IDE Approval for 60-Electrode Spinal Cord Stimulator System
May 21, 2022 15:46 ET | Micro-Leads Inc.
SOMERVILLE, Mass., May 21, 2022 (GLOBE NEWSWIRE) -- Micro-Leads Inc, a medical device technology company today announced FDA Investigational Device Exemption (IDE) approval for its high-definition...
Olympic Ophthalmics Announces FDA Clearance and Availability of Its Next-Generation iTEAR100 Neurostimulation Device, Expanded Patent Portfolio, and Further Clinical Studies
March 30, 2022 09:00 ET | Olympic Ophthalmics
ISSAQUAH, Wash., March 30, 2022 (GLOBE NEWSWIRE) -- Olympic Ophthalmics announced today that the U.S. Food and Drug Administration (FDA) has granted its 510(K) request for its second-generation...
SPR Therapeutics LOGO 361 TM.jpg
Prolonged Temporary Neurostimulation Treatment Period Offered by the SPRINT® PNS System May Optimize Pain Management Care Pathway While Reducing Healthcare Costs
March 15, 2022 10:31 ET | SPR Therapeutics, Inc.
CLEVELAND, March 15, 2022 (GLOBE NEWSWIRE) -- SPR Therapeutics announced publication of a study in the Journal of Pain Research demonstrating how a longer initial treatment period may better...
Logo transparent PNG.png
PathMaker Neurosystems Initiates U.S. Multi-Center Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
March 07, 2022 06:00 ET | PathMaker Neurosystems Inc.
BOSTON and PARIS, March 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Logo transparent PNG.png
PathMaker Neurosystems Awarded CERF Medical Electronics Prize for Amyotrophic Lateral Sclerosis
February 07, 2022 06:00 ET | PathMaker Neurosystems Inc.
BOSTON, Feb. 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...
ITGR LOGO (2019-09-25) intgr_ful_r_4cp_hor.png
Integer Holdings Corporation Completes Acquisition of Oscor, Inc.
December 02, 2021 08:30 ET | Integer Holdings Corporation
PLANO, Texas, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device outsource (MDO) manufacturer today announced the close of its acquisition of...
22157.jpg
Global Neuroprotection Markets to 2030: Major World Markets, Promising Areas of Research, Biological Therapies, Unmet Needs
November 23, 2021 06:18 ET | Research and Markets
Dublin, Nov. 23, 2021 (GLOBE NEWSWIRE) -- The "Neuroprotection - Methods, Drugs, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. This...
Spark Biomedical, Inc enlists the expertise of former Deputy Secretary of the U.S. Department of Health and Human Services, Eric D. Hargan, to help make novel opioid withdrawal treatment more accessible and affordable for patients
November 04, 2021 10:25 ET | Spark Biomedical
Dallas, TX, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Spark Biomedical, Inc, a leader in wearable neurostimulation for opioid withdrawal relief, today announced the Company will join forces with Eric D....
Logo transparent PNG.png
PathMaker Neurosystems Appoints Leading Neurotechnology Expert, John Donoghue, Ph.D., to Board of Directors
October 21, 2021 05:00 ET | PathMaker Neurosystems Inc.
BOSTON and PARIS, Oct. 21, 2021 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
22157.jpg
The Worldwide Neurostimulation Devices Industry is Expected to Reach $12.7+ Billion by 2026
September 06, 2021 09:43 ET | Research and Markets
Dublin, Sept. 06, 2021 (GLOBE NEWSWIRE) -- The "Neurostimulation Devices Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The neurostimulation...